Koers J. B. Chemicals & Pharmaceuticals Limited
Aandelen
JBCHEPHARM
INE572A01036
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.824 INR | +2,30% | +1,64% | +12,32% |
Omzet 2024 * | 35,01 mld. 421 mln. 393 mln. | Omzet 2025 * | 40,58 mld. 487 mln. 456 mln. | Marktkapitalisatie | 277 mld. 3,32 mld. 3,11 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 5,66 mld. 68,01 mln. 63,61 mln. | Nettowinst (verlies) 2025 * | 7,11 mld. 85,44 mln. 79,91 mln. | EV/omzet 2024 * | 7,95 x |
Nettoschuld 2024 * | 1,68 mld. 20,23 mln. 18,92 mln. | Nettoliquiditeiten 2025 * | 4,42 mld. 53,09 mln. 49,66 mln. | EV/omzet 2025 * | 6,71 x |
K/w-verhouding 2024 * |
45,9
x | K/w-verhouding 2025 * |
36,6
x | Werknemers | 5.095 |
Dividendrendement 2024 * |
0,68% | Dividendrendement 2025 * |
0,73% | Vrij verhandelbaar | 45,82% |
Recentste transcriptie over J. B. Chemicals & Pharmaceuticals Limited
1 dag | +2,30% | ||
1 week | +1,64% | ||
Lopende maand | +10,61% | ||
1 maand | +13,11% | ||
3 maanden | +7,97% | ||
6 maanden | +41,29% | ||
Lopend jaar | +12,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 05-10-20 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 59 | 31-08-20 | |
Akshay Tanna
BRD | Director/Board Member | 40 | 07/11 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 10-02-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - | |
0.00% | 117 M€ | +0,83% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1.824 | +2,30% | 4 047 |
23-04-24 | 1.783 | -0,16% | 4 204 |
22-04-24 | 1.786 | +0,44% | 2 693 |
19-04-24 | 1.778 | -0,92% | 2 477 |
18-04-24 | 1.795 | -0,02% | 19 935 |
uitgestelde koers Bombay S.E., 24 april 2024 om 12:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,32% | 3,32 mld. | |
+27,92% | 672 mld. | |
+26,76% | 570 mld. | |
-4,59% | 360 mld. | |
+16,38% | 321 mld. | |
+9,39% | 300 mld. | |
+7,36% | 217 mld. | |
+6,27% | 199 mld. | |
-8,96% | 204 mld. | |
-8,58% | 149 mld. |